Breaking News

Almac Receives Grant to Support COVID-19 Studies

Almac Clinical Services to provide clinical trial services from protocol through to patient delivery, and Almac Sciences will provide analytical support.

By: Contract Pharma

Contract Pharma Staff

Almac Group has received a $288,000 grant to support a clinical study in Sub-Saharan Africa in efforts to find a treatment for Coronavirus. This was awarded from the COVID-19 Therapeutics Accelerator, an initiative by the Bill & Melinda Gates Foundation, Wellcome and Mastercard. Almac Clinical Services is providing a full range of clinical trial services from protocol through to patient delivery, and Almac Sciences is providing analytical support from its global headquarters in Craigavon,...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters